Andrew Silvernail: You bet. I think like a lot of folks, we saw deceleration in Europe in, you know, starting in late summer, and that certainly continued into the fourth quarter. You know, at the same time it has not been a wholly negative story, so please don’t let anyone read into that. You know, our Europe has remained, I call it solid, but the growth rate certainly decelerated meaningfully in Europe – it started in the summer and into the fourth quarter.  Asia, I think we all saw some slowdown in the third quarter in Asia, and we saw it kick back up in the fourth quarter, and I think that trend is going to continue, really driven by what we are seeing out of China as we look into the balance of the year.Jim Lucas – Janney Montgomery Scott:  Okay, great, thank you very much.
Andrew Silvernail: You know, we don’t break that out. I will say that it’s a positive.Scott Graham – Jefferies & Co. :  It’s a positive.
Andrew Silvernail: Well, let me tackle two things, Scott, and that one around the debt, I just want to say first and foremost, I am really delighted with the team here and how they went about getting this debt placement, they did a terrific job, and when you think about it, we really have our path set in terms of capital structure for a very long period of time here. And you know, we have a tremendous amount of dry powder, it will be a very inexpensive rate as we utilize that, and you put that together with the strong free cash flow, and this really aligns us well to that billion to a billion two that we talked about being able to deploy over the next three years – so, first kudos to the team for that. On the M&A front, you know, Scott, when you said that 750, I had a couple of guys in the room kind of choke a little bit, but I got to resuscitate Heath. In all seriousness though, you know, if we do 200 to 300 million, you know, that would be a good year for us at 200 to 300 million in capital outlay, and that would be in line with our 1 billion to 1.2 billion dollar goal, and we’ve got a pretty good pipeline. You know, that being said, the nature of our pipeline is if more things broke our way, right, you could see that number creep pretty quickly as we saw in 2011. So, you know, a 200 to 300 would be solid, and if things break our way it could be significantly more than that. Scott Graham – Jefferies & Co. :  Thanks very much.
Andrew Silvernail: Hi, Matt. Matt Summerville – Keybanc Capital Markets: Sorry about that. It must have been the mute button. I was wondering if – with regards to FMT orders being down 1%, if we bucket that with oil and gas or energy and chemical, and Ag and other general industrial and then water, how those four buckets would have looked around, you know, that 1%. 
Andrew Silvernail: Sure. I think, you know, if you look at it long term, and you’re looking at HST as a whole, may I assume you’re referring to the fluidics piece, right? Matt Summerville – Keybanc Capital Markets: If you’d like to speak to the fluidics and the non-fluidics, I think that would be helpful as well. 
Andrew Silvernail: Okay. You know, on the fluidics side, you know, there are really two big driver to accelerated growth in that business. And, well, I’ll call it three big drivers. You’ve got one which is the m market itself and I do think, you know, as we move past these funding concerns, we’re going to see more like historical rates organically in that business. And all the market trends, I think, point in that direction over a three to five year period of time. So I think very favorably about that.  The second piece of the equation is new product introductions. And you know, if you look at 2010 and 2011, early 2011, for those of you who know that space well, there was some pretty big new product launches that came out to the marketplace that drove some incremental growth. And we obviously played well in those and did well.  And then the third piece, Matt, to your comment, is really around taking share. That’s a pretty consistent theme for us. You know, 2010, 2011, early 2011, we did better on some new stuff that came out, so that was positive. And we’ll still see some improvements. I will say though that if you look at the pipeline, our visibility into the pipeline of what’s being launched, which is not 100%, but it’s pretty good, you know, that’s not as robust in 2012, but I think overtime, that kind of cycles in two to four year cycles depending upon the market.  So you know, generally, matt, I feel good over the long term in terms of those three things. The other things you mentioned were really around price. You know, price is – has been okay for us, you know, we have – it’s not an environment where we’re going to go out and get a bunch of price. There’s no doubt about that. But it’s also not a deflationary environment. So I’ll call that a neutral.  So net-net, in the intermediate term, I think it’s about funding concerns and in the long-term, I really like how we’re positioned. Matt Summerville – Keybanc Capital Markets: Thanks a lot, Andy. 
Andrew Silvernail: That’s a great question, and the way we’ve kind of talked about it with everybody is, if you think about the end market, so the piece that we’re talking about here, Robert, is about 30% of HST, right. And HST is about 30% of IDEX so that’s kind of how we’ve talked about it. And the end market that that business touches, to one degree or another, if you look across the globe, NIH or NIH-like funding is about 30% of the money flows. That’s kind of how the math works.  So the – you know, our expectations, by the way, for those of you who have been watching, the NIH budget did not get cut as you looked at those actual results, 1%, you know ,for their fiscal year. I think they announced that in October or November. So you know, it was a little bit better than expected, but obviously with the election and what happens next year, we’ll see how that plays through. But other NIH-like bodies across the globe are more positive, especially when you look at Asia.  So specific to your question, how we’ve thought about that is we look at the first part of the year for that business to be pretty flat, you know, in terms of revenue. The first quarter being the most challenged, not necessarily because of the sequential order rates, Robert, but because, you know, the last 2012, Q1 2011 for that business was a monster. It was really a great quarter. We had a number of very large blanket orders and some pretty good sized product ramp ups. So first quarter is a pretty tough comp, second quarter is kind of flattish and then we expect to see very modest improvement in Q3 and 4.  So we are not modeling in or building a plan that has an expectation of a blowout rebound, which I think is the prudent thing to do for the balance of this year. 
Andrew Silvernail: You know, I think what you see is, you know, HST was actually up 2 in orders. No, I’m sorry. You said first quarter, Allison? Allison Poliniak – Wells Fargo Securities, Llc:  Yes, for January, sorry. 
Andrew Silvernail: My apologies. Actually, Allison, it’s very broad based. January was surprisingly broad based and so we feel, that’s one of the reasons that we feel pretty good about it. So there hasn’t been kind of a, you know, a massive move one way or the other. Allison Poliniak – Wells Fargo Securities, Llc:  Okay. 
Andrew Silvernail: Yes. You know, the bright spots for us in water have been – have certainly been outside the U.S. Now, I should say, outside the U.S. as you look east. The western markets, you know, still look a lot like the U.S. and I think that’s very fair to say. But the Asia markets and the Eastern European markets are – and Latin American are pretty solid. You know, so – and we expect that trend to kind of continue. And the other bright spot there has been the industrial water side. So the trends that we’ve been talking about here for quite some time are pretty consistent, and again, you know, we’ve built our annual operating plan and if you look at our – the actions that we have taken, the restructuring actions that we’ve taken, they’ve been focused around these businesses, including water where we’ve seen sluggishness. Allison Poliniak – Wells Fargo Securities, Llc: Okay, great. Thank you. 
Andrew Silvernail: You’ve got a few things in there. The most important is really looking at the kind of, you know, the blanket flash project orders that we comping against at the end of Q4. You know, Q1, you know, as we mentioned a moment ago, we’ve seen a pretty good start collectively across the board and so we have, as we look at that, that’s kind of the big thing, Charley, that’s in there is really looking at the blankets in the project. Other than that, you know, it’s just been a solid rebound and we’re encouraged by it. 
Andrew Silvernail: No, you know, we’re really not, and this time last year, if you all recall, there were a lot of concerns out there around inflation and around that question, Charley, around constraints. We really don’t see that at this point. I will say, however, that the – a major portion of the incremental investments that we’re making in 2012, and we’ll make more investments in 2013, are to improve our supply chain. We really think that an outstanding supply chain can be a significant competitive differentiator and we’re trying to build similar capability throughout the world that we built over the last three or four years in Asia and we think having a very strong regional supply chain capability is the right way to go in a world that is certainly converging. Charles Brady – BMO Capital Markets: Great. Thanks. 
Andrew Silvernail: I absolutely do. I think, you know, we’ve had a great history of driving productivity in the company. And as everyone knows, right, that bar gets raised a little bit every year and that’s a big piece, Scott, of putting more investment into the supply chain. You know, we want to drive that, and overtime, frankly, improve that. And also get the benefits of improved lead time and improved quality.  So yes, the answer is yes. That’s what we should expect herein 2012 and the answer is yes, that should be the expectation as we go forward. Scott Graham – Jefferies & Co.: Thanks very much. 
Andrew Silvernail: Well, everybody, thank you very much for taking the time this morning. Again, we’re delighted with how we finished the year and we’re pleased with how we’re seeing the start to 2012. We’re exceptionally proud of what the team has accomplished across IDEX and we look forward to having a solid year in 2012. And we’ll talk to you again in the first quarter. 
